Notice: This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Champions Oncology (NASDAQ:CSBR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage46.98%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$274,975.92Number OfInsiders Selling(Last 3 Years)0 Get CSBR Insider Trade Alerts Want to know when executives and insiders are buying or selling Champions Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CSBR Insider Buying and Selling by Quarter Champions Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Daniel Newman MendelsonDirectorBuy1,000$6.50$6,500.00 1/10/2024Daniel Newman MendelsonDirectorBuy2,944$6.31$18,576.64 1/8/2024Daniel Newman MendelsonDirectorBuy1,000$6.15$6,150.00 1/5/2024Daniel Newman MendelsonDirectorBuy2,000$6.09$12,180.00 1/3/2024Daniel Newman MendelsonDirectorBuy500$5.83$2,915.00 12/21/2023Daniel Newman MendelsonDirectorBuy2,500$4.92$12,300.00 12/19/2023Daniel Newman MendelsonDirectorBuy5,000$4.75$23,750.00 10/10/2023Daniel Newman MendelsonDirectorBuy1,100$6.41$7,051.00 10/5/2023Daniel Newman MendelsonDirectorBuy2,000$6.47$12,940.00 10/3/2023Daniel Newman MendelsonDirectorBuy2,500$6.30$15,750.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/29/2023Daniel Newman MendelsonDirectorBuy4,000$6.16$24,640.00 9/26/2023Daniel Newman MendelsonDirectorBuy5,000$5.65$28,250.00 9/21/2023Daniel Newman MendelsonDirectorBuy5,000$5.51$27,550.00 9/19/2023Daniel Newman MendelsonDirectorBuy5,000$5.28$26,400.00 3/17/2023Ronnie MorrisCEOBuy12,382$4.04$50,023.28 (Data available from 1/1/2013 forward) CSBR Insider Trading Activity - Frequently Asked Questions Who is on Champions Oncology's Insider Roster? The list of insiders at Champions Oncology includes Daniel Newman Mendelson, and Ronnie Morris. Learn more on insiders at CSBR. What percentage of Champions Oncology stock is owned by insiders? 46.98% of Champions Oncology stock is owned by insiders. Learn more on CSBR's insider holdings. Which Champions Oncology insiders have been buying company stock? The following insiders have purchased CSBR shares in the last 24 months: Daniel Newman Mendelson ($224,952.64), and Ronnie Morris ($50,023.28). How much insider buying is happening at Champions Oncology? Insiders have purchased a total of 51,926 CSBR shares in the last 24 months for a total of $274,975.92 bought. More Insider Trading Tools from MarketBeat Related Companies Cullinan Therapeutics Insider Ownership Compass Therapeutics Insider Ownership MeiraGTx Insider Ownership Humacyte Insider Ownership Tectonic Therapeutic Insider Ownership ProKidney Insider Ownership Monte Rosa Therapeutics Insider Ownership REGENXBIO Insider Ownership Aura Biosciences Insider Ownership Taysha Gene Therapies Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (NASDAQ:CSBR) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.